Cillo Umberto, Perri Giampaolo, Bassi Domenico, Pellegrini Riccardo, Canitano Nicola, Serafini Simone, Gringeri Enrico, Marchegiani Giovanni
Hepato-pancreato-biliary and Liver Transplant Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
Hepato-pancreato-biliary and Liver Transplant Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
HPB (Oxford). 2025 Jul 12. doi: 10.1016/j.hpb.2025.07.010.
Pancreatectomy with venous resection (PVR) is considered standard practice and accomplished with different techniques.
Patients undergoing PVR with portal (PV) and/or superior mesenteric (SMV) vein resection for PDAC between 2015 and 2024 at a high-volume HPB and Liver Transplant Unit were retrospectively analyzed according to ISGPS types.
A total of 104 patients underwent PVR: tangential w/primary closure (Type 1 = 30; 29 %) or peritoneal patch (Type 2 = 30; 29 %), segmental w/primary anastomosis (Type 3 = 31; 30 %) or interposition graft (Type 4 = 13; 12 %). Type 2 was mostly used for low (SMV-to-SMV = 37 %) or extended (PV-to-SMV = 50 %) resections (p < 0.001), with lowest rate of splenic vein sacrifice (7 %; p = 0.001). Major morbidity and hemorrhage (PPH) were similar among different ISGPS types (Type 2 = 27 % and 30 %, respectively), as well as mortality (Type 2 = 3 % at 90 days). Prophylactic dose anticoagulation was used in 73 % of Type 2 patients, with 3 % early (≤30 days) and no late (≤1 year) thrombosis.
The peritoneal patch offers the advantages of both tangential and segmental resections. It can be used for low or extended infiltrations, preserving venous collaterals without sacrificing radicality, with acceptable morbidity and mortality, and near-zero thrombotic events using prophylactic anticoagulation only.
胰腺切除术联合静脉切除(PVR)被视为标准术式,且可通过不同技术完成。
对2015年至2024年期间在一家大型肝脏胰腺胆道外科和肝移植中心因胰腺癌接受门静脉(PV)和/或肠系膜上静脉(SMV)切除的PVR患者,根据国际胰腺外科研究组(ISGPS)分型进行回顾性分析。
共有104例患者接受了PVR:切线切除并一期缝合(1型 = 30例;29%)或腹膜补片修补(2型 = 30例;29%),节段性切除并一期吻合(3型 = 31例;30%)或间置移植(4型 = 13例;12%)。2型主要用于低位(SMV对SMV = 37%)或扩大范围(PV对SMV = 50%)切除(p < 0.001),脾静脉牺牲率最低(7%;p = 0.001)。不同ISGPS分型的主要并发症和出血(PPH)相似(2型分别为27%和30%),90天死亡率也相似(2型为3%)。73%的2型患者使用了预防性抗凝,早期(≤30天)血栓形成率为3%,晚期(≤1年)无血栓形成。
腹膜补片兼具切线切除和节段性切除的优点。它可用于低位或广泛浸润性病变,保留静脉侧支而不牺牲根治性,并发症和死亡率可接受,仅使用预防性抗凝时血栓形成事件接近零。